OPERF
TXG icon

Oregon Public Employees Retirement Fund’s 10x Genomics TXG Stock Holding History

Oregon Public Employees Retirement Fund’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,474
Closed -$220K – 1704
2021
Q4 		$220K Sell
1,474
-14,200
-91% -$2.18M ﹤0.01% 1510
2021
Q3 		$2.28M Sell
15,674
-391
-2% -$67.1K 0.03% 546
2021
Q2 		$3.15M Buy
16,065
+810
+5% +$147K 0.04% 430
2021
Q1 		$2.76M Buy
15,255
+82
+0.5% +$14.2K 0.03% 444
2020
Q4 		$2.15M Buy
+15,173
New +$2.2M 0.03% 504

Other funds holding TXG

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
1WCM
12 West Capital Management New York $535M AUM 25.99% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Oregon Public Employees Retirement Fund's TXG Position: Q1 2022 in Review

Oregon Public Employees Retirement Fund sold out of 10x Genomics (TXG) in Q1 2022, closing a stake of 1,474 shares — an estimated $220K sold.

Oregon Public Employees Retirement Fund first reported a position in TXG in Q4 2020 and held it in 5 quarters. The position peaked at $3.15M in Q2 2021. 314 funds tracked by Wall St. Rank hold TXG as of Q1 2022.

  • Oregon Public Employees Retirement Fund reported no remaining 10x Genomics position as of Q1 2022 after selling out during the quarter.
  • Oregon Public Employees Retirement Fund sold 1,474 10x Genomics shares in Q1 2022, an estimated $220K.
  • Oregon Public Employees Retirement Fund first reported a position in 10x Genomics in Q4 2020 and held it in 5 quarters.
  • Oregon Public Employees Retirement Fund's 10x Genomics position peaked at $3.15M in Q2 2021.
  • 314 funds tracked by Wall St. Rank held 10x Genomics as of Q1 2022.

Based on Oregon Public Employees Retirement Fund's 13F filing for Q1 2022, filed 21 Apr 2022.